M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

NEWSWelcome to the May edition of the MASCC Society NewsMessage from Editors Anna Ugalde and Anna Boltong

With the MASCC Annual Meeting in Miami just around the corner (June 26-28, 2014), we look forward to bringing you stories from award winners, outstanding presentations and all the meeting-related news over the coming editions. In this edition, we are pleased to present a new book edited by a MASCC member Mario E. Lacouture, and include an overview of the content and details on how to order. MASCC has recently also created a new category of membership which we profile in this newsletter, allowing members who are retired (aged 65 or greater) to receive discounted membership. There are also three new members, numerous publications by MASCC members and details of how to apply to host the 2017 MASCC symposium. If you have any MASCC news or stories to share, please feel free to contact us directly on anna.ugalde@svhm.org.au or anna.boltong@cancervic.org.au

From your editors, Anna & Anna

May 2014

Call to Host MASCC

International Symposium

Until 1st June 2014, MASCC will accept applications to host the annual meeting, which will be selected to take place in the U n i t e d S t a t e s . P l e a s e g o t o w w w. m a s c c . o r g t o r e v i e w t h e requirements for the application. If you will apply, you will need to specify the U.S. city, identify the meeting Chair, provide dates, provide details about the event venue, hotels to provide delegates with options for accommodation, and list and describe any prior experiences hosting international oncology-related meetings. Applications will be presented to the MASCC board to vote and select the successful applicant. As is described in the information on the MASCC website, it will be expected that the successful applicant will work with the MASCC meeting planner for arrangements and planning. Upcoming confirmed Annual Meetings include Copenhagen, Denmark in 2015 and Adelaide, Australia in 2016.

A new book by a MASCC member is now available for purchaseDermatologic Principles and Practice in Oncology: Conditions of the Skin, Hair, and Nails in Cancer Patients, edited by Mario E. Lacouture, M.D. of Memorial Sloan-Kettering Cancer Center, is the first book to focus on common and frequently disabling side effects

of treatment that affect the skin, hair, and nails in cancer patients. It provides detailed descriptions of mechanism-of-action in all current oncology drugs and the clinical presentation and mechanisms underlying their dermatologic side effects. In addition, the book presents recommendations to

address these side effects that will allow physicians to significantly enhance the care of patients with cancer. This resource offers dermatologists and other practitioners a focused and comprehensive perspective on cancer-related skin conditions associated with cancer therapies. This book is published by Wiley-Blackwell. For more information, including how to order, please go to: http://www.wiley.com/WileyCDA/WileyTitle/

2 0 1 7

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Akhilanand Chaurasia My job title is Assistant Professor and Consultant, presently working in King George Medical University, Lucknow, India. I am an on-call consultant and I manage oral cancer patients suffering from post-radiation osteonecrosis, oral mucositis, hyposalivation, radiation caries and post-radiation trismus. I deliver training to oral cancer patients for proper oral hygiene maintenance post treatment. Oral cancer is an extremely common cancer in India; we encounter a number of cases daily. Since we are a developing country, facilities are limited - particularly in the context of providing supportive care. I joined MASSC/ISOO to get updated and stay connected to the field of supportive care, with the aim of contributing to improved quality life for my patients.

Karin B. Dieperink I am employed as a senior nurse by the Department of Oncology at Odense University Hospital, Denmark, and I work in cancer rehabilitation as a manager and researcher at the Rehabilitation Centre Dallund. The topics of my PhD included supportive care and rehabilitation after prostate cancer. During this research I gained an understanding of how important interdisciplinary collaboration is to \undertake high quality research and ultimately design and deliver evidence based clinical practice. I have participated in MASCC annual meetings in New York in 2012 and Berlin in 2013, and am I excited about participating in Miami 2014 as well. In the future, I will be more involved in family nursing and management of elderly cancer patients. As a member of MASCC, I hope to find international collaborators with the same interests.

William Fahl I am a Professor of Oncology in the McArdle Laboratory for Cancer Research at the University of Wisconsin (UW). My career research interest has been in how to design, synthesize and use small drug molecules to protect mammalian cells against radiation and chemical toxins. Most of my research has involved preclinical animal model studies at Wisconsin, but over the past 7 years it has also involved collaboration with clinical colleagues at UW and elsewhere to translate our preclinical findings into clinical studies to suppress radiotherapy and chemotherapy side effects in cancer patients. MASCC and ISOO provide a global forum for sharing data and study results. We had just achieved preclinical results showing complete prevention of oral mucositis in both mouse and hamster models, and identified the MASCC/ISOO annual meeting as the best place to share this outcome and work to establish partnerships for upcoming clinical studies.

Retirement Category for MASCC Membership If you are a member of MASCC who is retired (age 65 or greater), you may request a reduced membership fee. This new membership category has a fee of $50USD per year, with online access to the journal. It will be handled by the MASCC office, so if you have any questions, please contact MASCC Executive Director Åge Schultz, by email at: aschultz@mascc.org

Meet some new MASCC Members

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Publications from MASCC members

1: Shim JH, Song KY, Jeon HM, Park CH, Jacks LM, Gonen M, Shah MA, Brennan MF, Coit DG, Strong VE. Is Gastric Cancer Different in Korea and the United States? Impact of Tumor Location on Prognosis. Ann Surg Oncol. 2014 Mar 6.

2: Kavalieratos D, Kamal AH, Abernethy AP, Biddle AK, Carey TS, Dev S, Reeve BB, Weinberger M. Comparing Unmet Needs between Community-Based Palliative Care Patients with Heart Failure and Patients with Cancer. J Palliat Med. 2014 Mar 3.

3: Lawler M, Selby P, Aapro MS, Duffy S. Ageism in cancer care. BMJ. 2014 Feb 28;348:g1614.

4: Aapro M, Arends J, Bozzetti F, Fearon K, Grunberg SM, Herrstedt J, Hopkinson J, Jaquelin-Ravel N, Jatoi A, Kaasa S, Strasser F. Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force. Ann Oncol. 2014 Feb 25.

5: Blum D, Stene GB, Solheim TS, Fayers P, Hjermstad MJ, Baracos VE, Fearon K, Strasser F, Kaasa S; on behalf of Euro-Impact. Validation of the Consensus-Definition for Cancer Cachexia and evaluation of a classification model - A study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014 Feb 22.

6: Leblanc TW, Currow DC, Abernethy AP. On Goldilocks, care coordination, and palliative care: making it 'just right'. Prim Care Respir J. 2014 Feb 19.

7: Tewari KS, Sill MW, Long HJ 3rd, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, Monk BJ. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014 Feb 20;370(8):734-43.

8: Kryvenko ON, Haley SL, Smith SC, Shen SS, Paluru S, Gupta NS, Jorda M, Epstein JI, Amin MB, Truong LD. Hemangiomas In Kidneys With End-Stage Renal Disease: A Novel Clinicopathological Association. Histopathology. 2014 Feb 18.

9: Gibson F. What is it really like to be a young person, in our hospital, at this moment? Cancer Nurs. 2014 Mar-Apr;37(2):86-7.

10: Warren GW, Marshall JR, Cummings KM, Zevon MA, Reed R, Hysert P, Mahoney MC, Hyland AJ, Nwogu C, Demmy T, Dexter E, Kelly M, O'Connor RJ, Houstin T, Jenkins D, Germain P, Singh AK, Epstein J, Dobson Amato KA, Reid ME. Automated tobacco assessment and cessation support for cancer patients. Cancer. 2014 Feb 15;120(4):562-9.

11: de Boer EW, Dijkstra PU, Stegenga B, de Bont LG, Spijkervet FK. Value of cone-beam computed tomography in the process of diagnosis and management of disorders of the temporomandibular joint. Br J Oral Maxillofac Surg. 2014 Mar;52(3):241-6.

12: Wardill HR, Bowen JM, Gibson RJ. New pharmacotherapy options for chemotherapy-induced alimentary mucositis. Expert Opin Biol Ther. 2014 Mar;14(3):347-54.

13: Tan HL, Sood A, Rahimi HA, Wang W, Gupta N, Hicks J, Mosier S, Gocke CD, Epstein JI, Netto GJ, Liu W, Isaacs WB, De Marzo AM, Lotan TL. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma. Clin Cancer Res. 2014 Feb 15;20(4):890-903.

14: Patel HD, Feng Z, Landis P, Trock BJ, Epstein JI, Carter HB. Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer. J Urol. 2014 Mar;191(3):629-37.

15: Tracey E, Watt H, Currow D, Young J, Armstrong B. Investigation of poorer bladder cancer survival in women in NSW, Australia: a data linkage study. BJU Int. 2014 Mar;113(3):437-48.

16: Daniele G, Di Maio M, Piccirillo MC, Giordano P, Capuano I, Cecere SC, Bryce JC, Pignata S, Perrone F. New biological treatments for gynecological tumors: focus on angiogenesis. Expert Opin Biol Ther. 2014 Mar;14(3):337-46.

17. Molassiotis A, Kontopantelis E. Response to Letter to the Editor: Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time? Support Care Cancer. 2014 Apr;22(4):865-6.

M A S C C • S u p p o r t i v e C a r e m a k e s e x c e l l e n t c a n c e r c a r e p o s s i b l e

Multinational Association of Supportive Care in Cancer • www.mascc.org

Have any news items to share?

Please send contributions for the MASCC News to MASCCnews@mascc.org or the co-editors:

Anna Ugalde anna.ugalde@svhm.org.au and Anna Boltong anna.boltong@cancervic.org.au

For more information please contact: Åge Schultz, MASCC Executive Director: aschultz@mascc.org

Join MASCC before June 1st for up to $200in registration savings and bene!ts!